J&J gets FTC clearance to buy Synthes
19:17 EDT 11 Jun 2012 | PharmPro
Johnson & Johnson will have to sell its system for surgically treating serious wrist fractures to win federal clearance of its pending $21.3 billion acquisition of Synthes Inc.The New Brunswick, N.J., health care giant agreed to buy the Swiss orthop..
Original Article: J&J gets FTC clearance to buy Synthes
More From BioPortfolio on "J&J gets FTC clearance to buy Synthes"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
